Applied Materials vs. Amkor Technology: Which Artificial Intelligence Stock Is a Better Buy in 2026?

The article pitches Applied Materials (AMAT) vs. Amkor Technology (AMKR) as semiconductor bellwethers for AI-driven demand, citing AMAT FY2025 revenue of $28.4B (+4.4% YoY) and a 24.7% net margin, alongside FCF of $5.7B. It also highlights AI-tailwinds with AMAT guiding semiconductor equipment growth of >30% this year and AMKR growing 27% YoY revenue to $1.7B in Q1, with AMKR projecting $11B revenue by 2030. Offsetting risks include AMAT’s $252M export-violation settlement (Feb 2026) and Amkor’s customer concentration (top 10 customers = 72% of sales), leading to a valuation contrast—AMKR trades at 2.7x P/S vs AMAT at 17.0x with AMAT carrying a higher forward P/E (49.5x vs 34.7x sector benchmark).

Analysis

The market is likely underpricing how much of the AI packaging boom accrues to process-control and equipment vendors versus pure test/assembly providers. Advanced packaging is becoming a bottleneck, but that usually pushes bargaining power upstream to the customer with the roadmap and to the equipment layer that defines yields; it does not automatically translate into durable OSAT margin expansion. That makes AMKR the more cyclical, customer-concentrated way to play the theme, while AMAT has a cleaner path to convert capex into recurring service revenue and higher mix of installed-base demand.

Over the next 1-3 months, the key catalyst is not another AI headline but whether TSMC and large device customers extend packaging spend into 2027 budgets. If that happens, AMAT should re-rate faster because its earnings power is less dependent on a single customer order book and more on broad fab-tool spending. AMKR’s Arizona expansion is a double-edged sword: it can win strategic relevance, but it also introduces execution risk and likely caps near-term cash conversion, which matters more in a higher-rate environment.

Contrarian view: the low multiple on AMKR may be a value trap if customers use outsourced packaging tactically while retaining the option to insource once volumes scale. That risk is especially relevant for AAPL, NVDA, and QCOM, where design control can be paired with strategic packaging supply. The cleaner 6-18 month thesis is AMAT long on the idea that AI capex remains semi-structural, while China/export policy risk is a known overhang rather than a thesis-breaker unless restrictions widen further.

Key Decisions for Investors

• Prefer long AMAT / short AMKR as a relative-value pair for 3-6 months: AMAT has better margin durability, stronger FCF, and less customer concentration risk; use a 1:1 dollar-neutral structure and add on any AMKR rally into guidance events.
• For outright exposure, buy AMAT on pullbacks tied to export-control headlines rather than chasing strength; the setup is best if the stock sells off on policy noise while AI capex guidance from TSM/TSMC stays firm. Falsifier: a meaningful cut to 2026 equipment demand or widening China restrictions that hit bookings.
• Treat AMKR as a trading position only until Arizona execution milestones are de-risked; avoid paying for the 2030 growth story before evidence of incremental gross margin leverage appears. Falsifier: customer-qualified volume ramps and sustained FCF inflection over two quarters.
• Watch AAPL/NVDA/QCOM packaging spend and commentary as the real catalyst set for AMKR; if any of these shift toward internalization or multi-sourcing, AMKR’s multiple could compress further. Consider a hedge via short AMKR against long those customers if packaging insourcing rhetoric increases.
• If you want sector exposure without single-name execution risk, use SMH as a proxy but overweight AMAT inside the basket; that captures AI tool-chain upside with lower idiosyncratic downside than owning AMKR outright.